Skip to main content

Advertisement

SpringerLink
Log in

The Need to Prioritize and Re-prioritize Palliative Care Options: Smoking Cessation as a Case-in-Point

  • Palliative and Supportive Care (MP Davis, Section Editor)
  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

Palliative care in cancer patients requires a continuous reprioritization of effort. This review describes the need for this reprioritization and uses smoking cessation as a case-in-point. The treatment of patients with metastatic non-small cell lung cancer has changed dramatically in the past few years. Interestingly, patients who had previously smoked now have an improved prognosis—for a variety of reasons. This review discusses this last observation in detail and raises the question of how forcefully we should advise smoking cessation in patients with incurable metastatic non-small cell lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Fulton JJ, LeBlanc TW, Cutson TM, et al. Integrated outpatient palliative care for patients with advanced cancer: a systematic review and meta-analysis. Palliat Med. 2018:1–12.

  2. Temel JS, Greer JA, Muzikansy A, et al. Early palliative care for patients with metastatic non-small cell lung cancer. N Engl J Med. 2010;363:733–42.

    Article  CAS  Google Scholar 

  3. Barrera R, Shi W, Amar D, et al. Smoking and timing of cessation: impact of pulmonary complications after thoracotomy. Chest. 2005;127:1977–83.

    Article  Google Scholar 

  4. Tanner NT, Kanodra NM, Gebregziabher M, et al. The association between smoking abstinence and mortality in the National Lung Screening Trial. Am J Respir Crit Care Med. 2016;193:534–41.

    Article  CAS  Google Scholar 

  5. https://www.cancer.net/navigating-cancer-care/prevention-and-healthy-living/stopping-tobacco-use-after-cancer-diagnosis; last accessed January 22, 2019.

  6. Cataldo JK, Dubey S, Prochask JJ. Smoking cessation: an integral part of lung cancer treatment. Oncology. 2010;78:289–301.

    Article  Google Scholar 

  7. Lennes IT, Temel JS. Greer JA, et al. ASCO quality oncology practice initiative (QOPI) quality measures for smoking cessation and survival in metastatic non-small cell lung cancer. J Clin Oncol. 2011;29; abstract:6074.

    Article  Google Scholar 

  8. Li C, Marek M, Guclu SZ, et al. Smoking and prognostic factors in an observational setting in patients with advanced non-small cell lung carcinoma. 2011; 2:52–62.

  9. Kogure Y, Ando M, Saka H, et al. Histology and smoking status predict survival of patients with advanced non-small cell lung cancer. J Thorac Oncol. 2013;8:753–8.

    Article  Google Scholar 

  10. Desrichard A, Kuo F, Chowell D, et al. Tobacco smoking-associated alterations in the immune microenvironment of squamous cell carcinomas. J Natl Cancer Inst. 2018. 10.1093.

  11. Kim JH, Kim HS, Kim BJ. Prognostic value of smoking status in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis. Oncotarget 2017; 8:93149–93193,155. This meta-analysis points out the relationship between smoking and outcomes in patients who are receiving PD-L1 inhibitors.

  12. Li B, Huang X, Fu L. Impact of smoking on efficacy of PD-1/PD-L1 inhibitors in non-small cell lung cancer patients: a meta-analysis. Oncotargets Ther. 2018;11:3691–6.

    Article  Google Scholar 

  13. Norum J, Nieder C. Tobacco smoking cessation and PD-L1 inhibitors in non-small cell lung cancer: a review of the literature. ESMO Open 2018; e000406. This paper points out the relationship between smoking and outcomes in patients who are receiving PD-L1 inhibitors.

  14. Garon EB, Rizvi NA, Hui R, et al. Pembrolizumab for the treatment of non-small cell lung. N Eng J Med. 2015;372:2018–28.

    Article  Google Scholar 

  15. Reck M, Rodriguez-Abreu D, Robinson AG, et al. Pembrolizumab versus chemotherapy for PD-L1-positive non-small cell lung cancer. N Engl J Med. 2016;375:1823–33.

    Article  CAS  Google Scholar 

  16. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/cessation/quitting/index.htm; last accessed January 22, 2019.

  17. Halpern SD, Harhay MO, Saulsgiver K, et al. A pragmatic trial of e-cigarettes, incentives, and drugs for smoking cessation. N Engl J Med. 2018;378:2302–10.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA

    Konstantinos Leventakos MD, Anna J. Schwecke CNP, APRN, MS, Erin Deering CNP, APRN, Elizabeth Cathcart-Rake MD, Anna C. Sanh BS & Aminah Jatoi MD

Authors
  1. Konstantinos Leventakos MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna J. Schwecke CNP, APRN, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Erin Deering CNP, APRN
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elizabeth Cathcart-Rake MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anna C. Sanh BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Aminah Jatoi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aminah Jatoi MD.

Ethics declarations

Conflict of Interest

Konstantinos Leventakos, Anna J. Schwecke, Erin Deering, Elizabeth Cathcart-Rake, Anna C. Sanh, and Aminah Jatoi declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Palliative and Supportive Care

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Leventakos, K., Schwecke, A.J., Deering, E. et al. The Need to Prioritize and Re-prioritize Palliative Care Options: Smoking Cessation as a Case-in-Point. Curr. Treat. Options in Oncol. 20, 33 (2019). https://doi.org/10.1007/s11864-019-0632-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11864-019-0632-7

Keywords

Search

Navigation